Hepatitis A as an Etiologic Agent of Acute Liver Failure in Latin America

Ciocca, Mirta; Moreira-Silva, Sandra Fagundes; Alegria, S; Galoppo, María Cristina; Ruttiman, Ricardo; Porta, Gilda; Silvera, Themis Reverbel Da; Rubio, Pilar; Macías, M.; Cervantes, Yolanda; Ávila-Agüero, María Luisa; Clemens, Sue Ann Costa; Clemens, Ralf; Weil, J.

doi:10.1097/inf.0b013e3180f60bed

Cited by 67 publications

(43 citation statements)

References 25 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…4,6,7 Duval et al, 57 Immunity duration in low risk children born to HBsAg negative mothers, vaccinated soon after birth, is still under discussion. 51 In these individuals, the risk could reappear during adolescence and the beginning of sexual life.…”

Section: Hepatitis B Vaccinementioning

confidence: 99%

Prevenção das hepatites virais através de imunização

Ferreira¹,

Silveira²

2006

J. Pediatr. (Rio J.)

View full text Add to dashboard Cite

Objective: To present an updated review and criticism of viral hepatitis A and B prevention by immunization. Summary of the findings: Viral hepatitis prevention is an enormous challenge to the public health systems of countries and the medical and scientific communities. Hepatitis viruses produce important morbimortality in the world, causing acute and chronic hepatic disease. There are highly efficient vaccines available on the market to prevent new infections by the A and B viruses. However, A and B viruses continue to be among the most commonly notified diseases preventable by vaccines. In this article, we discuss the vaccines used to prevent these infections, with the aim of expanding knowledge and the practice of prevention of these infectious diseases.Conclusions: Although the vaccines against A and B hepatitis are recommended for various risk groups, estimated vaccine coverage is still modest and many vaccination opportunities are lost. In order to reduce the incidence of A and B hepatitis, which are preventable by vaccines, it is necessary for physicians to encourage their patients to be vaccinated.

show abstract

Section: Hepatitis B Vaccinementioning

confidence: 99%

Prevenção das hepatites virais através de imunização

Ferreira¹,

Silveira²

2006

J. Pediatr. (Rio J.)

View full text Add to dashboard Cite

show abstract

“…Specific diagnosis cannot be made in a majority of patients (2)(3)(4)(5)(6). Survival rates have been raised from 15% to 65% with liver transplantation.…”

Section: Introductionmentioning

confidence: 99%

Acute liver failure in children: 20-year experience

Barış

Saltık-Temizel²,

Uslu³

et al. 2012

Turk J Gastroenterol

View full text Add to dashboard Cite

show abstract

“…La frecuencia de las diferentes causas varía en las diferentes regiones. Para Chile, las principales causas son las infecciones virales e intoxicaciones 8,9 .…”

Section: Discussionunclassified

“…Al examen de ingreso se encontraba ictérica, con petequias y palidez. Se realizaron exámenes donde se encontró pancitopenia, con GB 1.700/uL, Hb 9 g%, PLT 14.000/uL y bioquímica alterada con BT 10 mg%, BD 7,8 Se realizó mielograma y citometría de flujo, los cuales mostraron presencia de LLA CALLA (+), con expresión parcial de CD20 y (9;22) negativa. De forma inmediata se inició tratamiento con esquema quimioterapia BFM con dexametasona a dosis de 20 mg/m 2 día, con lo que se observó normalización de las pruebas hepáticas (Tabla 1).…”

Section: Casounclassified